Cardarine or GW501516 is a PPAR-δ (peroxisome proliferator-activated receptor delta) that was concurrently developed by GlaxoSmithKline and Ligand Pharmaceuticals in 1992 for treatment of different metabolic and cardiovascular diseases. In 2007 research showed that Cardarine dramatically enhanced both endurance and strength...